touchPODCAST

touchpodcast
touchPODCAST

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.

  1. 19 DEC

    Advancing the treatment of muscle-invasive bladder cancer: Updates on immunotherapy in the perioperative setting

    touchEXPERT OPINIONS for touchONCOLOGYListen to an oncologist, urologist and oncology nurse highlight the key data for immunotherapy in the perioperative setting for muscle-invasive bladder cancer, practical considerations for its use in clinical practice, and how possible side effects can be monitored for and managed. They also consider the role of the multidisciplinary team in implementing this treatment modality.The experts Dr Laura Mertens, Netherlands Cancer Institute, Amsterdam, The Netherlands Prof. Thomas Powles, Barts Cancer Centre, London, UK Ms Lindsay Diamond, Icahn School of Medicine at Mount Sinai, New York, NY, USA This touchPODCAST is for healthcare professionals outside of the UK only.This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website:  www.touchONCOLOGY.com

    38 min

  2. 17 DEC

    Navigating treatment choices in high-risk early-stage melanoma - touchDERMATOLOGY

    touchEXPERT OPINIONS for touchDERMATOLOGY Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions. The experts Dr Tina J Hieken, Mayo Clinic, Rochester, MN, USA Prof. Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland Dr Teresa Amaral, Tübingen University, Tübingen, Germany This touchPODCAST is for healthcare professionals outside of the UK only This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.  For further information visit our website: https://touchdermaime.org/navigating_treatment_choices_in_high-risk_early-stage_melanoma

    34 min

  3. 17 DEC

    Navigating treatment choices in high-risk early-stage melanoma - touchONCOLOGY

    touchEXPERT OPINIONS for touchONCOLOGY  Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions. The experts Dr Tina J Hieken, Mayo Clinic, Rochester, MN, USA Prof. Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland Dr Teresa Amaral, Tübingen University, Tübingen, Germany This touchPODCAST is for healthcare professionals outside of the UK only This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.  For further information visit our website: https://touchoncologyime.org/navigating_treatment_choices_in_high-risk_early-stage_melanoma

    34 min

  4. 4 DEC

    Advances in IOL technology and power calculations: Updates and innovations from 2024

    touchFOCUS for touchOPHTHALMOLOGY Listen to Dr John Ladas, an expert in cataract surgery, as he answers a series of questions on intraocular lens power calculation, including how the use of artificial intelligence may help to improve accuracy, and provides an update on the latest advances in intraocular lens technology. The expert Dr John Ladas, Maryland Eye Consultants & Surgeons, Silver Spring, MD, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Johnson & Johnson Surgical Vision, Inc. and Carl Zeiss Meditec, Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchophthalmology.com/

    14 min

  5. 27 NOV

    Supporting healing in epidermolysis bullosa: Innovations and new directions for care

    touchFOCUS for touchDERMATOLOGYListen to Prof. Amy Paller as she answers a series of questions on the key features of epidermolysis bullosa, including its pathophysiology and clinical manifestations. In addition, she responds to questions on the role of new and emerging topical therapies for epidermolysis bullosa in patient care, with a focus on a multidisciplinary team approach.The expert: Prof. Amy Paller - Northwestern University Feinberg School of Medicine, Chicago, IL, USA This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical education grant from Chiesi USA Inc. This activity is jointly provided by USF Health and touchIME.For further information visit our website: touchDERMA.com

    19 min

  6. 14 NOV

    Primary biliary cholangitis: Appraising the changing therapeutic landscape

    touchEXPERT OPINIONS for touchIMMUNOLOGY Listen to a leading expert in hepatology as they explore the current and future management of primary biliary cholangitis.  The expert Dr Mitchell Shiffman - Bon Secours Liver Institute, Richmond, VA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational grant from Gilead Sciences Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchimmunologyime.org/Primary-biliary-cholangitis-therapeutic-landscape

    36 min

  7. 14 NOV

    Primary biliary cholangitis: Appraising the changing therapeutic landscape

    touchEXPERT OPINIONS for touchENDOCRINOLOGY Listen to a leading expert in hepatology as they explore the current and future management of primary biliary cholangitis.  The expert Dr Mitchell Shiffman - Bon Secours Liver Institute, Richmond, VA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational grant from Gilead Sciences Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website:  https://touchendocrinologyime.org/primary-biliary-cholangitis-therapeutic-landscape

    36 min

  8. 14 NOV

    touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4

    touchMDT for touchONCOLOGYListen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center,  Houston, TX, USA Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine,  Baltimore, MD, USA Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany This touchPODCAST is for HCPs outside the UK.This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.For further information visit our website:  www.touchONCOLOGY.com

    14 min
See All (100)

About

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.

Information

  • Creator
    touchpodcast
  • Years Active
    2020 - 2024
  • Episodes
    100
  • Rating
    Clean
  • Copyright
    © Copyright 2020 All rights reserved.
  • Show Website
    touchPODCAST

You Might Also Like

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada